Nordsjaellands Hospital, Hillerod

Hilleroed 3400

1 studies enrolling now · 4 studies all time

What they study most

Crohn Disease, Hypoparathyroidism, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Registry for Participants With Chronic Hypoparathyroidism — Completed
• A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed